Cardiology

Resource Center

Podcasts

Cardiometabolic Risk

Using an Oral Glucose Tolerance Test to Determine Prediabetes Risk

04/18/2017

Dr Stephanie Chung, from the National Institutes of Health, talks about her recent diabetes and glucose monitoring study.

04/18/2017

Research Summaries

COVID-19 ROUNDUP

Estimated Number of Adults With Long COVID, WHO Updates Terminology For Air Pathogens, Vaccination Reduces Risk of Cardiac Events, and More

05/06/2024

Anthony Calabro, MA

This COVID-19 roundup includes coverage on the latest estimated number of adults with long COVID, WHO’s updated terminology for pathogens that transmit through the air, how COVID-19 vaccination reduces the...

05/06/2024

Conference Coverage

Dextromethorphan-Bupropion Delays Relapse of Agitation Symptoms in Patients Diagnosed With Probable Alzheimer Disease

04/29/2024

Anthony Calabro, MA

Researchers evaluated the safety and efficacy of dextromethorphan-bupropion, an FDA approved treatment of major depression disorder, for Alzheimer disease-related agitation. This study was presented at the...

04/29/2024

Research Summary

Heart Rate Variability Associated With Increased Risk of Agitation Among Patients With Alzheimer Disease

04/24/2024

Anthony Calabro, MA

Researchers collected data from the Atherosclerosis Risk in Communities Study to determine whether heart rate variability was associated with agitation risk in individuals clinically diagnosed with dementia...

04/24/2024

Research Summary

Neuropsychiatric Symptoms Associated With Neuroinflammation in Patients With Alzheimer Disease

04/15/2024

Anthony Calabro, MA

Researchers set out to determine whether microglial activation, which can trigger neuroinflammation, is associated with neuropsychiatric symptoms that often accompany Alzheimer-associated dementias,...

04/15/2024

FDA ALERT

FDA Approves First Activin Signaling Inhibitor Therapy in Patients With PAH

04/12/2024

Jessica Bard

The FDA has approved sotatercept-csrk, the first activin signaling inhibitor therapy, for the management of patients with pulmonary arterial hypertension (PAH). Based on the Phase 3 STELLAR trial,...

04/12/2024

August 2024

Current Issue

August 2024